Proton pump inhibitors: Review of reported risks and controversies. Issue 6 (19th October 2018)

• Record Type: Journal Article
• Authors: Brisebois, Simon; Merati, Albert; Giliberto, John Paul
• Is Part Of: Laryngoscope investigative otolaryngology. Volume 3:Issue 6(2018)
• Page Start: 457
• Page End: 462
• Publication Date: 2018-10-19
• Subjects: Proton Pump Inhibitors risks -- laryngopharyngeal reflux -- gastroesophageal reflux disease; Otolaryngology -- Periodicals; Laryngoscopy -- Periodicals; Otolaryngology; Otolaryngology; Periodicals; Periodicals; 617.51
• DOI: 10.1002/lio2.187
• Languages: English
• ISSNs: 2378-8038

Abstract

Abstract : Proton pump inhibitors (PPIs) are among the most prescribed classes of drugs in this day and age. These may be beneficial to treat many gastrointestinal conditions, such as gastroesophageal reflux or Barrett's esophagus as well as laryngopharyngeal reflux. However, many reports have emerged in the literature exposing the potential association of PPIs with various risks and complications such as bone fracture, infection, myocardial infarction, renal disease, and dementia. This review highlights many of these potential adverse side effects by exploring relevant publications and addressing the controversies associated with those findings. The diligent otolaryngologist should be aware of the current state of the literature and the risks associated with prescribing PPIs to insure proper counseling of their patients. Level of Evidence: 5